Michael Jansen, MD
Clinical Cardiac Electrophysiology · Gainesville, FLNPI 1740302587
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,050 of the $27,359 with a category attached, or 76.9%. Boston Scientific accounts for 73.7% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $11,740, 3.0 times the $3,950 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.
Across 232 payments — averaging $117.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$20K
- Elutia, Inc.$3K
- Biosense Webster, Inc.$2K
- Medtronic$731
- Pfizer$291
- Novartis$231
- plus $1K from 21 others
What the payments were for
- Consulting fees$400%
- Speaking & faculty fees$21,05077%
- Travel & lodging$1,0834%
- Food & beverage$5,17619%
- Gifts$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 51 | $20,158 |
| Elutia, Inc. | 6 | $3,176 |
| Biosense Webster, Inc. | 51 | $1,577 |
| Medtronic(2 entities) | 21 | $731 |
| Pfizer | 18 | $291 |
| Novartis | 11 | $231 |
| E.r. Squibb & Sons, L.L.C. | 18 | $223 |
| Amgen | 11 | $184 |
| Bardy Diagnostics, Inc. | 14 | $128 |
| Celonova Biosciences, Inc. | 1 | $100 |
| Johnson & Johnson | 5 | $81 |
| Baxter Healthcare | 3 | $77 |
| Kestra Medical Technology Services, Inc. | 2 | $56 |
| Merck | 3 | $51 |
| Biotronik Inc. | 3 | $45 |
| Cvrx, Inc. | 2 | $44 |
| Abbott | 2 | $34 |
| Cordis US CORP. | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Atricure, Inc. | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Cardiva Medical, Inc. | 1 | $13 |
| Acutus Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$9,600
- ECM Patch,Pouch$3,000
- GENERAL BRADY$1,200
- Carto 3$348
- Carto 3 System$225
- SelectSecure$141
- THERMOCOOL SMARTTOUCH$114
- COBALT DR MRI SURESCAN$102
How this compares
$27,359 in reported general payments places this provider in the 50th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 659 | $677,982 |
| EntrestoSacubitril/Valsartan | 144 | $135,271 |
| XareltoRivaroxaban | 170 | $134,472 |
| JardianceEmpagliflozin | 111 | $84,767 |
| FarxigaDapagliflozin Propanediol | 54 | $47,828 |
| Repatha SureclickEvolocumab | 44 | $31,552 |
| MultaqDronedarone Hcl | 13 | $19,722 |
| CorlanorIvabradine Hcl | 13 | $9,619 |
| Dofetilide | 28 | $8,455 |
| Flecainide Acetate | 227 | $7,281 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 24 | $6,687 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 201 | $6,047 |
| Metoprolol Succinate | 444 | $5,686 |
| Atorvastatin Calcium | 331 | $2,942 |
| SotalolSotalol Hcl | 163 | $2,685 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $291 | $677,982659 claims |
| NovartisEntresto | $231 | $135,271144 claims |
| Johnson & JohnsonXarelto | $81 | $134,472170 claims |
| AstraZenecaFarxiga | $19 | $47,82854 claims |
| Sanofi-aventis U.S. LLCMultaq | $20 | $19,72213 claims |
| AmgenCorlanor | $184 | $9,61913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Gainesville
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
- Marcelo JimenezAtlantis$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.